Professor Paul Garner

  • Co-ordinator, Evidence Synthesis for Global Health, Liverpool School of Tropical Medicine;
  • Co-ordinating Editor of the Cochrane Infectious Diseases Group;
  • Director of the Effective Health Care Research Consortium

I am responsible for the Centre for Evidence Synthesis for Global Health  at the Liverpool School of Tropical Medicine (LSTM). I was part of the original team that set up the Cochrane Collaboration, and currently I am one of the co-ordinating editors of the Cochrane Infectious Diseases Group.  We lead a network of over 300 people synthesizing research to inform global, regional and national policies in tropical infections and conditions relevant to low- and middle-income countries. We work with the World Health Organization and several countries in guideline development, hold a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases. I am Director of a DFID Research Consortium, the Effective Health Care Research Consortium, working with colleagues in South Africa, Kenya, Malawi, Nigeria, Cameroon, India, Norway and China. I have honorary Professorship appointments with Chongqing Medical University; Christian Medical College, Vellore; and Stellenbosch University.


Co-convener of the research synthesis postgraduate module (LSTM).

Research Grants (current)

£8 Million. Garner P. Effective Health Care Research Consortium. DFID (UK), 2010-18.

USD 8K. Garner P (working with Sue Hill and Holger Schünemann). Appraisal of the clinical guideline development process in Estonia. WHO, 2015.

£85K. Garner P, Ollier L (with Peter Heywood and Paula Waugh). Evaluation and organizational learning of TDR’s approach and models of the TDR Capacity Strengthening Grant Schemes and Regional Training Centres. TDR/WHO, 2015-16.

External Appointments

Editorial Board, PLOS Medicine (2017-)
Member of the WHO Expert Advisory Panel on the review of the causality framework between Zika virus infection and neurological disorders (2016)
Member of the WHO Malaria Technical Guidelines Group for malaria treatment and the WHO Operational Guidelines Group in HIV/AIDS (2015)
Member of the WHO Expert Advisory Panel on Drug Evaluation (2015)
Innovation and Review production Senior Adviser, Cochrane Library Editorial Board  (2018-)

Consultant in Public Health with Public Health England (academic honorary contract)
Fellow, Faculty of Public Health Medicine
Senior Research Fellow, WINDREF, St George’s Medical School, Grenada
Extraordinary Professor in  Epidemiology and Biostatistics, Stellenbosch University   
Honorary Professor, Christian Medical College, Vellore
Honorable Professor, Chongqing Medical University, Chongqing.

Selected publications

  • Zika virus infection: update on the evidence for a causal link to congenital brain abnormalities and Guillain-Barré syndrome (Zika causality statement) September 2016

    The Selection and Use of Essential Medicines Report of the World Health Organization Expert Committee, 2015 (Technical Report Series 994) April 2015

    Garner P, Brabin B. A review of randomized controlled trials of malaria prophylaxis during pregnancy in endemic malarious areas. Bulletin of the World Health Organization 1994; 72: 89-99. [systematic review].

    Olliaro P, Nevill C, Ringwald P, Mussano P, Garner P, Brasseur P. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 1996; 348: 1196-1201. [systematic review].

    Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003343. DOI: 10.1002/14651858.CD003343.pub2.

    Singh A, Garner P, Floyd K. Cost-effectiveness of options for cataract surgery in India. Lancet2000; 355: 180-184.

    Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD002847. DOI: 10.1002/14651858.CD002847.

    International Artemisinin Study Group. Artesunate combinations for treating uncomplicated malaria: A prospective individual patient data meta-analysis. Lancet 2004; 363:9-17 (corresponding author).

    World Health Organization. Guidelines for the treatment of malaria. World Health Organization. Roll Back Malaria Dept, 2006 [member of the Technical Guidelines Development Group and Guidelines Drafting Committee].

    Gordon S, Baker A, Duten A and Garner P. Study exploring the evidence relating Health and Conflict: interventions and outcomes. Commissioned by the UK Cross Government Group on Health and Conflict. London: 2010.

    Berendes S, Heywood P, Oliver S, Garner P. Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies. PLoS Medicine 2011; 8(4): e1000433.

    Kayentao K, Garner P, van-Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis." JAMA 2013; 309(6): 594-604.

    Sinclair D, Gyansa-Lutterodt M, Asare B, Koduah A, Andrews E, Garner P, et al. (2013) Integrating Global and National Knowledge to Select Medicines for Children: The Ghana National Drugs Programme. PLoS Medicine 10(5): e1001449. doi:10.1371/journal.pmed.1001449.

    Sinclair D, Isba R, Kredo T, Zani B, Smith H, Garner P. (2013) World Health Organization Guideline Development: An Evaluation. PLoS One 8(5): e63715. doi:10.1371/journal.pone.0063715.